South Korea, as the World Health Organization's (WHO) Biomanufacturing Workforce Training Hub leader, initiated training for vaccine production processes. This training was jointly promoted by the South Korean government and the Asian Development Bank (ADB) for 35 trainees from 12 low- and middle-income countries.
In terms of strengthening South Korea's ability to respond to future infectious diseases, the Ministry of Health and Welfare (MOHW) and Ministry of Economy and Finance (MOEF) signed a letter of intent with ADB in October 2021 to expand vaccine production and distribution, and support strengthening health systems in low- and middle-income member countries. They launched the K-NIBRT (National Institute for Bioprocessing Research and Training) Group, an institution that establishes education infrastructure including international standards for good manufacturing practices and provides professional training to foster manpower in bioproduction processes.
This training is South Korea's first global education push after the country was designated as the WHO Bio-manufacturing Workforce Training Hub global leader. To boost local pharmaceutical production, South Korea will play a key role in training that provides high-quality vaccine and bio-production programs to participating countries.